Cargando…
Association of Anemia With Epilepsy and Antiepileptic Drugs
Epilepsy is a disorder that causes unprovoked seizures regularly. It affects between 1% and 3% of the population. After the first seizure, the chances of having another one are almost 40%-52%. The etiology of febrile seizures in children with sickle cell disease is still unknown. In some groups, iro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653853/ https://www.ncbi.nlm.nih.gov/pubmed/34909297 http://dx.doi.org/10.7759/cureus.19334 |
_version_ | 1784611752556625920 |
---|---|
author | Padda, Jaskamal Khalid, Khizer Syam, Mohammad Kakani, Varsha Kankeu Tonpouwo, Gauvain Dhakal, Richa Padda, Sandeep Cooper, Ayden Charlene Jean-Charles, Gutteridge |
author_facet | Padda, Jaskamal Khalid, Khizer Syam, Mohammad Kakani, Varsha Kankeu Tonpouwo, Gauvain Dhakal, Richa Padda, Sandeep Cooper, Ayden Charlene Jean-Charles, Gutteridge |
author_sort | Padda, Jaskamal |
collection | PubMed |
description | Epilepsy is a disorder that causes unprovoked seizures regularly. It affects between 1% and 3% of the population. After the first seizure, the chances of having another one are almost 40%-52%. The etiology of febrile seizures in children with sickle cell disease is still unknown. In some groups, iron deficiency anemia has been linked to an increased risk of seizures. Although the reason and process are uncertain, some people believe that taking iron supplements can help prevent seizures. This literature covers haptene, non-haptene immune-related hemolysis, and oxidative processes activated by anti-seizure medications (ASMs). In epileptic patients, ASMs can cause anemia. Folic acid can be given to carbamazepine-treated anemic patients. There is growing evidence that it improves hemoglobin and leukocytes in individuals who take it. Therefore, one of the most efficient strategies to avoid future seizures is to take ASMs daily to maintain an even level of anticonvulsant in the body. To prevent further seizures, lifestyle changes are essential. Further studies and clinical trials are warranted to prove a clear association between epilepsy and hematologic disease, which will improve quality of life in the future. |
format | Online Article Text |
id | pubmed-8653853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86538532021-12-13 Association of Anemia With Epilepsy and Antiepileptic Drugs Padda, Jaskamal Khalid, Khizer Syam, Mohammad Kakani, Varsha Kankeu Tonpouwo, Gauvain Dhakal, Richa Padda, Sandeep Cooper, Ayden Charlene Jean-Charles, Gutteridge Cureus Internal Medicine Epilepsy is a disorder that causes unprovoked seizures regularly. It affects between 1% and 3% of the population. After the first seizure, the chances of having another one are almost 40%-52%. The etiology of febrile seizures in children with sickle cell disease is still unknown. In some groups, iron deficiency anemia has been linked to an increased risk of seizures. Although the reason and process are uncertain, some people believe that taking iron supplements can help prevent seizures. This literature covers haptene, non-haptene immune-related hemolysis, and oxidative processes activated by anti-seizure medications (ASMs). In epileptic patients, ASMs can cause anemia. Folic acid can be given to carbamazepine-treated anemic patients. There is growing evidence that it improves hemoglobin and leukocytes in individuals who take it. Therefore, one of the most efficient strategies to avoid future seizures is to take ASMs daily to maintain an even level of anticonvulsant in the body. To prevent further seizures, lifestyle changes are essential. Further studies and clinical trials are warranted to prove a clear association between epilepsy and hematologic disease, which will improve quality of life in the future. Cureus 2021-11-07 /pmc/articles/PMC8653853/ /pubmed/34909297 http://dx.doi.org/10.7759/cureus.19334 Text en Copyright © 2021, Padda et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Padda, Jaskamal Khalid, Khizer Syam, Mohammad Kakani, Varsha Kankeu Tonpouwo, Gauvain Dhakal, Richa Padda, Sandeep Cooper, Ayden Charlene Jean-Charles, Gutteridge Association of Anemia With Epilepsy and Antiepileptic Drugs |
title | Association of Anemia With Epilepsy and Antiepileptic Drugs |
title_full | Association of Anemia With Epilepsy and Antiepileptic Drugs |
title_fullStr | Association of Anemia With Epilepsy and Antiepileptic Drugs |
title_full_unstemmed | Association of Anemia With Epilepsy and Antiepileptic Drugs |
title_short | Association of Anemia With Epilepsy and Antiepileptic Drugs |
title_sort | association of anemia with epilepsy and antiepileptic drugs |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653853/ https://www.ncbi.nlm.nih.gov/pubmed/34909297 http://dx.doi.org/10.7759/cureus.19334 |
work_keys_str_mv | AT paddajaskamal associationofanemiawithepilepsyandantiepilepticdrugs AT khalidkhizer associationofanemiawithepilepsyandantiepilepticdrugs AT syammohammad associationofanemiawithepilepsyandantiepilepticdrugs AT kakanivarsha associationofanemiawithepilepsyandantiepilepticdrugs AT kankeutonpouwogauvain associationofanemiawithepilepsyandantiepilepticdrugs AT dhakalricha associationofanemiawithepilepsyandantiepilepticdrugs AT paddasandeep associationofanemiawithepilepsyandantiepilepticdrugs AT cooperaydencharlene associationofanemiawithepilepsyandantiepilepticdrugs AT jeancharlesgutteridge associationofanemiawithepilepsyandantiepilepticdrugs |